MENU

PTHS

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Pelthos Therapeutics (PTHS) Ownership - Who owns Pelthos Therapeutics?

Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

101.77M

P/E Ratio

N/A

Total Cash

31.98M

Projected Growth

N/A

Total Debt

26.58M

Revenue

27.7M

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

9.20

Total Debt/Equity

N/A

Revenue/Share

10.84 USD as % of share price

View a ticker or compare two or three

VS

VS

PTHS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PTHS

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details